Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
4:00pm EDT
Change (% chg)

$0.00 (+0.20%)
Prev Close
$0.41
Open
$0.40
Day's High
$0.41
Day's Low
$0.40
Volume
176,267
Avg. Vol
1,601,383
52-wk High
$1.82
52-wk Low
$0.12

Latest Key Developments (Source: Significant Developments)

Akers Biosciences Says Terminated Raymond Akers Positions As Executive Chairman
Thursday, 26 Apr 2018 02:01am EDT 

April 26 (Reuters) - Akers Biosciences Inc ::SAYS TERMINATED RAYMOND AKERS POSITIONS AS EXECUTIVE CHAIRMAN, CHIEF SCIENTIFIC DIRECTOR AND SECRETARY OF COMPANY.SAYS APPOINTED RICHARD CARLYLE TARBOX III AS INTERIM NON-EXECUTIVE CHAIRMAN.  Full Article

Akers Biosciences Expands Outsourced U.S. Distribution Capabilities For Heparin PF4 Rapid Test
Thursday, 12 Apr 2018 07:00am EDT 

April 12 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES EXPANDS OUTSOURCED US DISTRIBUTION CAPABILITIES FOR HEPARIN PF4 RAPID TEST.AKERS BIOSCIENCES INC - AGREEMENTS WITH OPTO-SYSTEMS AND HERZOG SURGICAL TO INCREASE U.S. SALES FOR RAPID TEST.  Full Article

Akers Biosciences Reports Earnings For Fiscal Year 2017
Tuesday, 3 Apr 2018 07:03am EDT 

April 3 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES REPORTS EARNINGS FOR FISCAL YEAR 2017.  Full Article

Akers Biosciences Files For Non Timely 10-K SEC Filing‍
Tuesday, 3 Apr 2018 06:50am EDT 

April 3 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES FILES FOR NON TIMELY 10-K - SEC FILING‍.  Full Article

Akers Biosciences Announces Distribution Agreement With Diagnostica Stago​
Monday, 26 Mar 2018 02:43am EDT 

March 26 (Reuters) - Akers Biosciences Inc ::‍DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO​.‍ENTERED INTO 3-YEAR DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO FOR SALE OF CO'S RAPID TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA ACROSS US​.  Full Article

Bigger Capital Fund Reports An 8 Pct Passive Stake In Akers Biosciences
Tuesday, 2 Jan 2018 04:30pm EST 

Jan 2 (Reuters) - Biosciences Inc ::BIGGER CAPITAL FUND LP REPORTS AN 8 PCT PASSIVE STAKE IN AKERS AS OF DEC 21, 2017 - SEC FILING.  Full Article

Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences
Friday, 22 Dec 2017 02:19pm EST 

Dec 22 (Reuters) - Alpha Capital Anstalt::ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING.  Full Article

Akers Biosciences says Q3 revenue rose 10 pct to $675,800
Wednesday, 15 Nov 2017 07:00am EST 

Nov 15 (Reuters) - Akers Biosciences Inc -:Akers Biosciences announces Q3 2017 earnings.Q3 revenue rose 10 percent to $675,800.Akers Biosciences Inc - ‍Q3 gross margin reduced to 52%​.  Full Article

Akers Biosciences Inc Q2 revenue up 25 pct
Tuesday, 15 Aug 2017 07:00am EDT 

Aug 15 (Reuters) - Akers Biosciences Inc ::Akers Biosciences announces Q2 2017 earnings.Q2 revenue rose 25 percent to $1.2 million.Qtrly loss before income tax reduced by 34% to $666,647.  Full Article

Akers Biosciences Q2 revenue $1.2 million
Thursday, 3 Aug 2017 11:39am EDT 

Aug 3 (Reuters) - Akers Biosciences Inc ::Akers Biosciences announces second quarter trading update.Q2 revenue $1.2 million.  Full Article

BRIEF-Akers Biosciences Files Non Timely 10-Q - SEC Filing

* AKERS BIOSCIENCES INC FILES NON TIMELY 10-Q - SEC FILING Source text: (https://bit.ly/2k6a2jr) Further company coverage: